
CHRNA4 Antilichaam - N-terminalgebied: FITC (ARP34965_P050-FITC)
Kwaliteit
ISO Gecertificeerd
Levering
24-48 uur
Technische Specificaties
Cholinergic receptor, nicotinic, alpha 4 (neuronal)
EBN, BFNC, EBN1, NACHR, NACRA4, NACHRA4
1137
P43681
NP_000735
• Rabbit
Human, Mouse, Rat, Cow, Dog, Guinea Pig, Horse, Rabbit, Zebrafish
The immunogen is a synthetic peptide directed towards the N terminal region of human CHRNA4
CHRNA4 is a nicotinic acetylcholine receptor, which belongs to a superfamily of ligand-gated ion channels that play a role in fast signal transmission at synapses. These pentameric receptors can bind acetylcholine, which causes an extensive change in conformation that leads to the opening of an ion-conducting channel across the plasma membrane. This protein is an integral membrane receptor subunit that can interact with either nAChR beta-2 or nAChR beta-4 to form a functional receptor. Mutations in this gene cause nocturnal frontal lobe epilepsy type 1. Polymorphisms in this gene that provide protection against nicotine addiction have been described. This gene encodes a nicotinic acetylcholine receptor, which belongs to a superfamily of ligand-gated ion channels that play a role in fast signal transmission at synapses. These pentameric receptors can bind acetylcholine, which causes an extensive change in conformation that leads to the opening of an ion-conducting channel across the plasma membrane. This protein is an integral membrane receptor subunit that can interact with either nAChR beta-2 or nAChR beta-4 to form a functional receptor. Mutations in this gene cause nocturnal frontal lobe epilepsy type 1. Polymorphisms in this gene that provide protection against nicotine addiction have been described. Sequence Note: This RefSeq record was created from transcript and genomic sequence data to make the sequence consistent with the reference genome assembly. The genomic coordinates used for the transcript record were based on transcript alignments. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.
Ubqln1; CSNK2B; VSNL1; CHRNB4; CHRNB2; YWHAH; CRELD2
• Polyclonal
FITC: Fluorescein Isothiocyanate
Polyclonal Antibody
WB
Affinity Purified
0.5 mg/ml
Cow: 86%; Dog: 93%; Guinea Pig: 100%; Horse: 86%; Human: 100%; Mouse: 100%; Rabbit: 86%; Rat: 100%; Zebrafish: 93%
Liquid. Purified antibody supplied in 1x PBS buffer.
All conjugated antibodies should be stored in light-protected vials or covered with a light protecting material (i.e. aluminum foil) . Conjugated antibodies are stable for at least 12 months at 4C. If longer storage is desired (24 months), conjugates may be diluted with up to 50% glycerol and stored at -20C to -80C. Freezing and thawing conjugated antibodies will compromise enzyme activity as well as antibody binding.
67kDa
Fedi, M., (2008) J. Clin. Endocrinol. Metab. 93 (2), 634-637
Wet Ice
627
CHRNA4
CHRNA4
Rabbit
Neuronal acetylcholine receptor subunit alpha-4
NM_000744
AEERLLKKLFSGYNKWSRPVANISDVVLVRFGLSIAQLIDVDEKNQMMTT
Alpha-4
Beschrijving
CHRNA4 Antilichaam - N-terminalgebied: FITC (ARP34965_P050-FITC) Beschikbaar in 100 µL. Bestel eenvoudig online met snelle levering.
Specificaties
Recent bekeken producten

TRPM4-IN-2
BA7024-1
1 mg

TRPM4-IN-1
HY-122605-01
5 mg

Anti-RAVV Envelope glycoprotein/GP Recombinant Antibody (SAA2752)
VK160013-01
50 µg

Recombinant BoHV-1 Envelope glycoprotein E
DRA167-01
50 µg

GelRed® Agarose LE
#41029-5G
1x 5 g

50 ml Disposable Serological Pipette
CPP00050
100/CS

Sodium taurocholate
529535
5.0g

Sodium Taurocholate
289448-01
5 g
Recent gezochte producten

Trpm4 AAV siRNA Pooled Vector
48523166
1.0 µg

TRPM4 siRNA Oligos set (Human)
48523171
3x 5 nmol

TRPM4 Protein Lysate
OCOA09977-20UG
20 µg

Lentiviral mouse Trpm4 shRNA (UAS) - Lentiviral mouse Trpm4 shRNA (UAS, RFP) (25)
GTR15228191
1 Vial

Anti-TRPM4 Antibody Picoband®
PB9902
100 µg/Vial

Brophenexin (NMDAR/TRPM4-IN-2) 5mg
A24124-5
5 mg

PMSCV-TRPM4 (human) -FLAG-PGK-Puro
BZ34636
1 Vial

NMDAR/trpm4 inhibitor 19
GIC99427-01
50 mg
